Major Depressive Disorder

DSM V categorise these as seperate disorders
- Depressive disorders
- Bipolar disorders
- Anxiety disorders
Depressive Disorders
- Major depressive disorder
- Other depressive disorder
- Persistent Depressive Disorder
- Substance/medication induced depression disorder
- Depressive disorder due to another medical condition
Overview
Depressive disorders are typically characterised by persistent low mood, loss of interest and enjoyment, neurovegetative disturbance, and reduced energy, causing varying levels of social and occupational dysfunction. Depression is the leading cause of disability and premature death in 18-44 yo and is predicated to be the 2nd leading cause of disability in 2020. 20% of adults will have it at some point in their life, women are twice as likely. Depression will make up ~5-10% of people seen in primary care setting.
Definition
Anhedonia: Loss of interest or pleasure in activities that were previously pleasurable
Depression: Clinical Depression is an illness, a medical condition. It significantly affects the way someone feels, causing a persistent lowering of mood.
Grief: Multifaceted response to loss, particularly to the loss of someone or something that has died, to which a bond or affection was formed.
| Grief | Depression |
| There is an identifiable loss | A specific loss may or may not be identified |
| The person’s focus is on the loss | The person’s focus is on self |
| Fluctuating ability to feel pleasure | Inability to feel pleasure |
| Fluctuating physical symptoms | Prolonged and marked functional impairment |
| Closeness of others is usually comforting | Persistent isolation from other and self |
| Able to feel a wide range of emotions | Fixed emotions and feeling “stuck” |
| May express guilt over some aspects over loss | Generalised feelings of guilt |
| Thoughts of death are typically related to wanting to be reunited with the deceased loved one | Thoughts of death related to feeling worthless, undeserving of life or unable to cope with the pain |
Aetiology & Risk Factors
Aetiology
Multifactorial
Changes in brain
- No structural abnormalities
- Function abnormalities present:
- Decreased activity in frontal lobe
- Increased firing in the limbic system
- Increase cortisol in blood
- Altered neurotransmitter pathways
- Serotonin
- Dopamine
- Noradrenaline
| Risk Factors |
| Age (onset peaks in late 20s) |
| Family history (3x risk with affected 1° relatives) |
| Personal history |
| Lower SES |
| Substance abuse |
| Adverse life events |
| Lack of confiding relationship |
| Physical illness |
Clinical Manifestations
Mneumonic SIG-E-CAPS for the signs and symptoms of Depression.
- Sleep changes
- Interest (decreased)
- Guilt (excessive)
- Energy (decreased)
- Concentration (decreased)
- Appetite changes
- Psychomotor agitation or retardation
- Suicidal ideation
Non-specific symptoms of Depression
- Abdominal pain
- Back pain
- Change in weight or appetite
- Constipation
- Fatigue
- Headache
- Insomnia or hypersomnia
- Joint pain
- Neck pain
- Weakness
- Bipolar Disorder
- Grief reaction
- Anxiety
- Hypothyroidism
- Multiple Sclerosis
- Dementia
- Other depressive disorder
- Persistent Depressive Disorder
- Substance/medication induced depression disorder (illicit drug withdrawal, antihypertensives, steroids)
- Depressive disorder due to another medical condition
Rule out an underlying substance (eg, alcohol and cocaine withdrawal), medication (eg, antihypertensives, steroids), or medical condition causing depression (eg, hypothyroidism, multiple sclerosis), especially if the patient does not have a prior history of depression.
Investigations
- FBC (anaemia, infectious diseases)
- ESR
- EUC
- LFT
- Urinalysis – uraemia
- Thyroid function tests – hypothyroidism
- ECG – dysrhythmia -> cerebral infarct
Diagnosis
- 1 core symptom
- At least 4 associated symptoms (SIG-E-CAPS)
- Sleep changes
- Interest (decreased)
- Guilt (excessive)
- Energy (decreased)
- Concentration (decreased)
- Appetite changes
- Psychomotor agitation or retardation
- Suicidal ideation
Criteria for symptoms
- Pervasive (all day, most days)
- Persistent (2 weeks)
- Not better explained
- No manic or hypomanic episodes
- New signs and symptoms then normal that impact with daily function
Treatment
The treatment that was successful for prior episodes of major depression has a higher likelihood of achieving remission in future episodes.
Psychological therapy
- Cognitive behavioural therapy
- Interpersonal therapy
Psychosocial treatments are first line treatments for mild depression. Usually psychotherapy is used in conjunction with pharmacotherapy.
Pharmacological therapy
- SSRI (first line)
- Certraline
- SNRI
- Desvanlafaxine
- TCA
- Amytriptaline
- Other
- Mertazapine (safe in pregnancy)
None has been shown to be more effective then the other, so the choice depends on the adverse effects the patient can tolerate. SNRI are used first line because they generally have less side effects. When response to treatment is poor the diagnosis and compliance with treatment should be reassessed
important to identify if patient also has manic episodes in the past, as antidepressent can induce a manic episode.
Adults with major depressive disorder being treated with antidepressants should be observed for worsening depressed mood and suicidality, especially during the initial few months of a course of drug therapy, or at times of dose changes (either increases or decreases).
Pharmacology
Selective serotonin reuptake inhibitors (SSRI) work by inhibiting the reuptake of serotonin from the synativ cleft thus increase serotonin effects on post synaptic neurons (causing good feels). Lower starting doses are often recommended and slowly increase and titrate accordingly. Side effects: Diarrhea, dizziness, dry mouth, fatigue, headache, sexual dysfunction, sweating, tremor, and weight gain are commonly reported. Nausea and vomiting are the most common reasons for discontinuation. Overdose of SSRI leads to serotonin syndrome (more info below).
Moderate/severe depression:
- Electro Convulsive Therapy
- Transcranial Magnetic Stimulation
Complications & Prognosis
- Sexual dysfunction and Gastrointestinal disturbance of SSRIs and SNRIs
- Risk of self-injurious behaviour
- Undesired weight gain from antidepressant
Risk of suicide with SSRI (increase risk in young, risk decreases in old >25years).
- Complete remission of symptoms and return to normal functioning are the therapy goals.
- For patients in their first episode of depression, treatment to remission may take up to several months and should be continued for a minimum of 9 to 12 months after remission.
- For patients who have had recurrent episodes, or in whom relapse or recurrence would likely convey a high risk, evidence supports prolonged antidepressant treatment.
More than 50% of patients who have had one episode of major depression will have recurrent episodes.
Postpartum Depression
Many experience what is known as postpartum blues, in which there is sadness, strong feelings of dependency, frequent crying spells, and dysphoria. This occurs in up to one in seven women.
Postpartum blues usually last for several days to a week. In rare cases, postpartum depression exceeds in both severity and length that is observed in postpartum blues and is characterized by suicidality and severely depressed feelings.
All women should be screened for depression during pregnancy and the postpartum period.
Risk factors
- History of depression
- Family history
- Mental illness
- Recent stressful life events
- Poor social support
- Discontinuing pharmaceutical treatments
- Exposure to violence
Diagnosis
For first-time mothers, adolescent mothers, and mothers who have experienced a traumatic delivery, home health visits, telephone-based peer support, and psychotherapy may help prevent peripartum depression.
- Mild to moderate depression – psychotherapy or selective serotonin reuptake inhibitors (SSRI’s)
- Moderate to severe depression – combination of psychotherapy and medication (SSRI’s are the safest)
Serotonin Syndrome
Selective serotonin reuptake inhibitors are the most commonly used medications for depression but should not be used in conjunction with MAOIs. One medication should be discontinued for at least 5 weeks before the other is initiated to avoid serotonin syndrome.
Serotonin syndrome is characterized by (in order of appearance) diarrhea, restlessness, extreme agitation, hyperreflexia, autonomic instability, myoclonus, seizures, hyperthermia, rigidity, delirium, coma, and death.















Members only discussions coming soon…